Terms: = Lymphoma AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Clinical Outcome
6 results:
1. Impact of imaging modality on clinical outcome in Hodgkin lymphoma in a resource constraint setting.
Korula A; Devasia AJ; Kulkarni U; Abubacker FN; Lakshmi KM; Abraham A; Srivastava A; George B; Mathews V
Br J Haematol; 2020 Mar; 188(6):930-934. PubMed ID: 31811734
[TBL] [Abstract] [Full Text] [Related]
2. Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma.
Park HY; Lee SB; Yoo HY; Kim SJ; Kim WS; Kim JI; Ko YH
Oncotarget; 2016 Dec; 7(52):86433-86445. PubMed ID: 27835906
[TBL] [Abstract] [Full Text] [Related]
3. Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis.
Patrij K; Reiser M; Wätzel L; Pels H; Kowoll A; Herrlinger U; Engert A; Linnebank M; Schackert G; Vogt-Schaden M; Egerer G; Lamprecht M; Batchelor TT; Schlegel U; Schmidt-Wolf IG;
Ger Med Sci; 2011; 9():Doc11. PubMed ID: 21698087
[TBL] [Abstract] [Full Text] [Related]
4. Serum cholesterol levels in neutropenic patients with fever.
Fraunberger P; Hahn J; Holler E; Walli AK; Seidel D
Clin Chem Lab Med; 2002 Mar; 40(3):304-7. PubMed ID: 12005222
[TBL] [Abstract] [Full Text] [Related]
5. Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome.
Goasguen JE; Lamy T; Bergeron C; Ly Sunaram B; Mordelet E; Gorre G; Dossot JM; Le Gall E; Grosbois B; Le Prisé PY; Fauchet R
Leuk Lymphoma; 1996 Nov; 23(5-6):567-76. PubMed ID: 9031088
[TBL] [Abstract] [Full Text] [Related]
6. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
[TBL] [Abstract] [Full Text] [Related]
